Cytarabine
Cytarabine, Depocyt, Vyxeos (cytarabine) is a small molecule pharmaceutical. Cytarabine was first approved as Cytarabine on 1982-01-01. It is used to treat leukemia, lymphoma, and meningeal neoplasms in the USA. It has been approved in Europe to treat myeloid leukemia acute.
| Trade Name | Vyxeos liposomal, known as Vyxeos |
|---|---|
| Common Name | Cytarabine |
| Indication | leukemia, lymphoma, meningeal neoplasms, myeloid leukemia acute |
| Drug Class | Antineoplastics (arabinofuranosyl derivatives) |
